{"bundle_type":"pith_open_graph_bundle","bundle_version":"1.0","pith_number":"pith:2024:2OLT5OOWHJDA33KKKYAFRLR3PK","short_pith_number":"pith:2OLT5OOW","canonical_record":{"source":{"id":"2411.08698","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.ME","submitted_at":"2024-11-13T15:40:36Z","cross_cats_sorted":[],"title_canon_sha256":"794f39490628afdac6c9bcf2079754d93c55b099a82136f57861720828a9b7d6","abstract_canon_sha256":"fc43dc5d9fc65960f37a93ae14d0d47b648749b4009543d0750d48d13531fde4"},"schema_version":"1.0"},"canonical_sha256":"d3973eb9d63a460ded4a560058ae3b7a86eeb8bc2c153c16be090025dc5779fc","source":{"kind":"arxiv","id":"2411.08698","version":1},"source_aliases":[{"alias_kind":"arxiv","alias_value":"2411.08698","created_at":"2026-07-05T09:35:01Z"},{"alias_kind":"arxiv_version","alias_value":"2411.08698v1","created_at":"2026-07-05T09:35:01Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2411.08698","created_at":"2026-07-05T09:35:01Z"},{"alias_kind":"pith_short_12","alias_value":"2OLT5OOWHJDA","created_at":"2026-07-05T09:35:01Z"},{"alias_kind":"pith_short_16","alias_value":"2OLT5OOWHJDA33KK","created_at":"2026-07-05T09:35:01Z"},{"alias_kind":"pith_short_8","alias_value":"2OLT5OOW","created_at":"2026-07-05T09:35:01Z"}],"events":[{"event_type":"record_created","subject_pith_number":"pith:2024:2OLT5OOWHJDA33KKKYAFRLR3PK","target":"record","payload":{"canonical_record":{"source":{"id":"2411.08698","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.ME","submitted_at":"2024-11-13T15:40:36Z","cross_cats_sorted":[],"title_canon_sha256":"794f39490628afdac6c9bcf2079754d93c55b099a82136f57861720828a9b7d6","abstract_canon_sha256":"fc43dc5d9fc65960f37a93ae14d0d47b648749b4009543d0750d48d13531fde4"},"schema_version":"1.0"},"canonical_sha256":"d3973eb9d63a460ded4a560058ae3b7a86eeb8bc2c153c16be090025dc5779fc","receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-07-05T09:35:01.184504Z","signature_b64":"EfmLu55T6bseNg5ceNiOTIr8sptHomYzoHvN1SHjoC5cZoup4y2Mbr+qNCG/+GoC6Nlkk5Y7UAJ3n/N2KHpQCw==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"d3973eb9d63a460ded4a560058ae3b7a86eeb8bc2c153c16be090025dc5779fc","last_reissued_at":"2026-07-05T09:35:01.184096Z","signature_status":"signed_v1","first_computed_at":"2026-07-05T09:35:01.184096Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"source_kind":"arxiv","source_id":"2411.08698","source_version":1,"attestation_state":"computed"},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-07-05T09:35:01Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"JPVNnvLP+MIwcDk5amp11PI9ZWV/HpRtVnZBR4Qd2HUyaZLNCKDpNUqvN2agThTKQzPnm1J1HWBTd6R76LhVAQ==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-08-07T22:14:58.633306Z"},"content_sha256":"e803e641f04bdb02c439f88a02f902d9332ff839eeb1b6035c8836ee46d4db2a","schema_version":"1.0","event_id":"sha256:e803e641f04bdb02c439f88a02f902d9332ff839eeb1b6035c8836ee46d4db2a"},{"event_type":"graph_snapshot","subject_pith_number":"pith:2024:2OLT5OOWHJDA33KKKYAFRLR3PK","target":"graph","payload":{"graph_snapshot":{"paper":{"title":"Statistical Operating Characteristics of Current Early Phase Dose Finding Designs with Toxicity and Efficacy in Oncology","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":[],"primary_cat":"stat.ME","authors_text":"Eunhee Kim, Hao Sun, Hsin-Yu Lin, Jieqi Tu, Revathi Ananthakrishnan","submitted_at":"2024-11-13T15:40:36Z","abstract_excerpt":"Traditional phase I dose finding cancer clinical trial designs aim to determine the maximum tolerated dose (MTD) of the investigational cytotoxic agent based on a single toxicity outcome, assuming a monotone dose-response relationship. However, this assumption might not always hold for newly emerging therapies such as immuno-oncology therapies and molecularly targeted therapies, making conventional dose finding trial designs based on toxicity no longer appropriate. To tackle this issue, numerous early phase dose finding clinical trial designs have been developed to identify the optimal biologi"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2411.08698","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"integrity":{"clean":true,"summary":{"advisory":0,"critical":0,"by_detector":{},"informational":0},"endpoint":"/pith/2411.08698/integrity.json","findings":[],"available":true,"detectors_run":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938"},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"verdict_id":null},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-07-05T09:35:01Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"mSFpUVLbJlHbHcUicTqr/RzCDCR3RcUQhQl4rgTFxrik6xq6mm0rRDEDxRu/5PWcz6ZkIYJ1maKvS8T3cEhACw==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-08-07T22:14:58.633687Z"},"content_sha256":"00186644899400dc1c57ea8e351d72972ce17a5d608e964e28b90590d74d8550","schema_version":"1.0","event_id":"sha256:00186644899400dc1c57ea8e351d72972ce17a5d608e964e28b90590d74d8550"}],"timestamp_proofs":[],"mirror_hints":[{"mirror_type":"https","name":"Pith Resolver","base_url":"https://pith.science","bundle_url":"https://pith.science/pith/2OLT5OOWHJDA33KKKYAFRLR3PK/bundle.json","state_url":"https://pith.science/pith/2OLT5OOWHJDA33KKKYAFRLR3PK/state.json","well_known_bundle_url":"https://pith.science/.well-known/pith/2OLT5OOWHJDA33KKKYAFRLR3PK/bundle.json","status":"primary"}],"public_keys":[{"key_id":"pith-v1-2026-05","algorithm":"ed25519","format":"raw","public_key_b64":"stVStoiQhXFxp4s2pdzPNoqVNBMojDU/fJ2db5S3CbM=","public_key_hex":"b2d552b68890857171a78b36a5dccf368a953413288c353f7c9d9d6f94b709b3","fingerprint_sha256_b32_first128bits":"RVFV5Z2OI2J3ZUO7ERDEBCYNKS","fingerprint_sha256_hex":"8d4b5ee74e4693bcd1df2446408b0d54","rotates_at":null,"url":"https://pith.science/pith-signing-key.json","notes":"Pith uses this Ed25519 key to sign canonical record SHA-256 digests. Verify with: ed25519_verify(public_key, message=canonical_sha256_bytes, signature=base64decode(signature_b64))."}],"merge_version":"pith-open-graph-merge-v1","built_at":"2026-08-07T22:14:58Z","links":{"resolver":"https://pith.science/pith/2OLT5OOWHJDA33KKKYAFRLR3PK","bundle":"https://pith.science/pith/2OLT5OOWHJDA33KKKYAFRLR3PK/bundle.json","state":"https://pith.science/pith/2OLT5OOWHJDA33KKKYAFRLR3PK/state.json","well_known_bundle":"https://pith.science/.well-known/pith/2OLT5OOWHJDA33KKKYAFRLR3PK/bundle.json"},"state":{"state_type":"pith_open_graph_state","state_version":"1.0","pith_number":"pith:2024:2OLT5OOWHJDA33KKKYAFRLR3PK","merge_version":"pith-open-graph-merge-v1","event_count":2,"valid_event_count":2,"invalid_event_count":0,"equivocation_count":0,"current":{"canonical_record":{"metadata":{"abstract_canon_sha256":"fc43dc5d9fc65960f37a93ae14d0d47b648749b4009543d0750d48d13531fde4","cross_cats_sorted":[],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.ME","submitted_at":"2024-11-13T15:40:36Z","title_canon_sha256":"794f39490628afdac6c9bcf2079754d93c55b099a82136f57861720828a9b7d6"},"schema_version":"1.0","source":{"id":"2411.08698","kind":"arxiv","version":1}},"source_aliases":[{"alias_kind":"arxiv","alias_value":"2411.08698","created_at":"2026-07-05T09:35:01Z"},{"alias_kind":"arxiv_version","alias_value":"2411.08698v1","created_at":"2026-07-05T09:35:01Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2411.08698","created_at":"2026-07-05T09:35:01Z"},{"alias_kind":"pith_short_12","alias_value":"2OLT5OOWHJDA","created_at":"2026-07-05T09:35:01Z"},{"alias_kind":"pith_short_16","alias_value":"2OLT5OOWHJDA33KK","created_at":"2026-07-05T09:35:01Z"},{"alias_kind":"pith_short_8","alias_value":"2OLT5OOW","created_at":"2026-07-05T09:35:01Z"}],"graph_snapshots":[{"event_id":"sha256:00186644899400dc1c57ea8e351d72972ce17a5d608e964e28b90590d74d8550","target":"graph","created_at":"2026-07-05T09:35:01Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"graph_snapshot":{"author_claims":{"count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","strong_count":0},"builder_version":"pith-number-builder-2026-05-17-v1","claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"integrity":{"available":true,"clean":true,"detectors_run":[],"endpoint":"/pith/2411.08698/integrity.json","findings":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938","summary":{"advisory":0,"by_detector":{},"critical":0,"informational":0}},"paper":{"abstract_excerpt":"Traditional phase I dose finding cancer clinical trial designs aim to determine the maximum tolerated dose (MTD) of the investigational cytotoxic agent based on a single toxicity outcome, assuming a monotone dose-response relationship. However, this assumption might not always hold for newly emerging therapies such as immuno-oncology therapies and molecularly targeted therapies, making conventional dose finding trial designs based on toxicity no longer appropriate. To tackle this issue, numerous early phase dose finding clinical trial designs have been developed to identify the optimal biologi","authors_text":"Eunhee Kim, Hao Sun, Hsin-Yu Lin, Jieqi Tu, Revathi Ananthakrishnan","cross_cats":[],"headline":"","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.ME","submitted_at":"2024-11-13T15:40:36Z","title":"Statistical Operating Characteristics of Current Early Phase Dose Finding Designs with Toxicity and Efficacy in Oncology"},"references":{"count":0,"internal_anchors":0,"resolved_work":0,"sample":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2411.08698","kind":"arxiv","version":1},"verdict":{"created_at":null,"id":null,"model_set":{},"one_line_summary":"","pipeline_version":null,"pith_extraction_headline":"","strongest_claim":"","weakest_assumption":""}},"verdict_id":null}}],"author_attestations":[],"timestamp_anchors":[],"storage_attestations":[],"citation_signatures":[],"replication_records":[],"corrections":[],"mirror_hints":[],"record_created":{"event_id":"sha256:e803e641f04bdb02c439f88a02f902d9332ff839eeb1b6035c8836ee46d4db2a","target":"record","created_at":"2026-07-05T09:35:01Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"attestation_state":"computed","canonical_record":{"metadata":{"abstract_canon_sha256":"fc43dc5d9fc65960f37a93ae14d0d47b648749b4009543d0750d48d13531fde4","cross_cats_sorted":[],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.ME","submitted_at":"2024-11-13T15:40:36Z","title_canon_sha256":"794f39490628afdac6c9bcf2079754d93c55b099a82136f57861720828a9b7d6"},"schema_version":"1.0","source":{"id":"2411.08698","kind":"arxiv","version":1}},"canonical_sha256":"d3973eb9d63a460ded4a560058ae3b7a86eeb8bc2c153c16be090025dc5779fc","receipt":{"algorithm":"ed25519","builder_version":"pith-number-builder-2026-05-17-v1","canonical_sha256":"d3973eb9d63a460ded4a560058ae3b7a86eeb8bc2c153c16be090025dc5779fc","first_computed_at":"2026-07-05T09:35:01.184096Z","key_id":"pith-v1-2026-05","kind":"pith_receipt","last_reissued_at":"2026-07-05T09:35:01.184096Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","receipt_version":"0.3","signature_b64":"EfmLu55T6bseNg5ceNiOTIr8sptHomYzoHvN1SHjoC5cZoup4y2Mbr+qNCG/+GoC6Nlkk5Y7UAJ3n/N2KHpQCw==","signature_status":"signed_v1","signed_at":"2026-07-05T09:35:01.184504Z","signed_message":"canonical_sha256_bytes"},"source_id":"2411.08698","source_kind":"arxiv","source_version":1}}},"equivocations":[],"invalid_events":[],"applied_event_ids":["sha256:e803e641f04bdb02c439f88a02f902d9332ff839eeb1b6035c8836ee46d4db2a","sha256:00186644899400dc1c57ea8e351d72972ce17a5d608e964e28b90590d74d8550"],"state_sha256":"ba9775f3fbd43279fa439ff3aa6427137e23ea198014cc3ce5f96827098fb706"},"bundle_signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"mnyWoG0BjdTA2yQHQAMqaseJbqgP6kYuyJ2P4b9mcJfGPiTa2M/zEye4dlNbypo32RPgy+ZKvrSlpNWoRjSAAQ==","signed_message":"bundle_sha256_bytes","signed_at":"2026-08-07T22:14:58.636472Z","bundle_sha256":"00d11359a9c3a5dc0d0e4ec094232cbd20ebdf8ea4b20764607d8241fbadcf0f"}}